Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07ONP
|
||||
| Former ID |
DAP000501
|
||||
| Drug Name |
Phenacemide
|
||||
| Synonyms |
Acetylureum; Carbanmide; Cetylureum; Comitiadone; Eferon; Efron; Epheron; Epiclase; Felurea; Fenacemid; Fenacemida; Fenacemide;Fenacetamide; Fenilep; Fenised; Fenostenyl; Fenural; Fenurea; Fenurone; Fenylacetylmocovina; Fenytan; Neophedan; Neophenal; Phacetur; Phenacalum; Phenacemidum; Phenacereum; Phenacerum; Phenacetur; Phenacetylcarbamide; Phenacetylurea; Phenarone; Phenicarb; Phenuron; Phenurone; Phenutal; Phenylacetylurea; Phenylacetyluree; Phenyrit; Phetylureum; Carbamide phenylacetate; Fenacemide [DCIT]; Fenylacetylmocovina [Czech]; Phenylacetyluree [French]; A-1348; Alpha-Phenylacetylurea; Fenacemida [INN-Spanish]; Fenacetil-karbamide; Phenacemide [INN:BAN]; Phenacemidum [INN-Latin]; Phenurone (TN); Sym-PHENYLACETYLUREA; N-(Aminocarbonyl)benzeneacetamide; Phenacemide (JAN/INN); N-carbamoyl-2-phenylacetamide; N-(aminocarbonyl)-2-phenylacetamide; (2-phenylacetyl)urea; (Phenylacetyl)urea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticonvulsants
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H10N2O2
|
||||
| InChI |
InChI=1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)
|
||||
| InChIKey |
XPFRXWCVYUEORT-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 63-98-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9632, 95062, 3135452, 7703588, 7847570, 8149472, 8152916, 10531448, 11335495, 11360734, 11363817, 11366379, 11368941, 11371697, 11374085, 11377103, 11461706, 11484913, 11488835, 11490495, 11492288, 11494737, 12016132, 15322023, 26611865, 26679403, 26748194, 26748195, 29223837, 46508400, 47216688, 48184906, 48184907, 48416401, 50061547, 50107353, 50869644, 51075754, 57322428, 85789582, 92124040, 92307466, 99301408, 103240106, 104307325, 117525543, 118307341, 124638054, 125729199, 129721316
|
||||
| SuperDrug ATC ID |
N03AX07
|
||||
| SuperDrug CAS ID |
cas=000063989
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Blocker | [536316] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| Ref 538401 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 007707. | ||||
| Ref 542284 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7265). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.